Published On: Wed, Oct 19th, 2016

Merge Healthcare Incorporated. (NASDAQ:MRGE) Latest Broker Coverage


A number of investment brokers have recently updated their price targets on shares of Merge Healthcare Incorporated. (NASDAQ:MRGE).

Most recent broker ratings

08/07/2015 – Merge Healthcare Incorporated. had its “hold” rating reiterated by analysts at Topeka Capital Markets. They now have a USD 7.1 price target on the stock.

08/07/2015 – Merge Healthcare Incorporated. was downgraded to “neutral” by analysts at Robert W. Baird.

08/06/2015 – Merge Healthcare Incorporated. was downgraded to “sell” by analysts at Dougherty & Co.

03/10/2015 – Merge Healthcare Incorporated. had its “neutral” rating reiterated by analysts at Zacks. They now have a USD 4.25 price target on the stock.

03/03/2014 – Merge Healthcare Incorporated. was upgraded to “hold” by analysts at Thomson Reuters/Verus.

The share price of Merge Healthcare Incorporated. (NASDAQ:MRGE) was up +0.00% during the last day of trading, with a day high of 0.00. 0 shares were traded during the last session.

The stock’s 50 day moving average is 7.10 and its 200 day moving average is 5.64.Merge Healthcare Incorporated. has a 52-week low of 2.13 and a 52-week high of 7.13.

Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company’s Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers. The Company’s Merge DNA (Data and Analytics) segment focuses on the marketing and sale of data capture software for clinical trials and related solutions. The Merge Healthcare segment offers licensing of software (including upgrades), the sale of hardware, professional services, maintenance and electronic data interchange (EDI) services. The Merge DNA segment offers on-premise licensing and hosting arrangements, and professional services.